Today, with more than 40 cancer immunotherapy indications and over 2,000 clinical trials, immunotherapy has become all but cemented in the future oncological treatment. It is therefore of upmost importance that clinicians are able to recognise and manage cutaneous toxicities – the most common immune related adverse event.
We would like to invite dermatologists, medical oncologists, registrars, advanced trainees, interested BPTs, nurses, and any other medical practitioner in joining us for a morning of education on the practicalities of diagnosing and treating skin effects of anti-cancer therapies – from targeted and immuno-therapies to classic chemotherapy.
Skin Effects of Systemic Anti-Cancer Therapies
Department of Dermatology, Westmead Hospital
When: Saturday 24th of November 2018. Registration begins at 8.30am.
Where: Case Study Room, Westmead Education and Conference Centre, Level 1, Westmead Hospital.
Skin Effects of Systemic Anti-Cancer Therapies
Last Updated on 16 October 2018 by Prof Fernandez-Peñas